Galaxy Asset Management: December 2024 Month End AUM

Galaxy Digital Holdings Ltd. (TSX: GLXY)(“Galaxy”) announced that its affiliate, Galaxy Asset Management, (“GAM”), reported preliminary assets under management of $5.7 billion as of December 31, 2024. The 6.5% decrease in preliminary AUM compared to the prior month was primarily driven by market depreciation and net outflows from GAM's Passive Funds. Note – we will […]

ROSEN, A LEADING LAW FIRM, Encourages Micron Technology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MU

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Micron Technology, Inc. (NASDAQ:MU) between September 28, 2023 and December 18, 2024, both dates inclusive (the "Class Period").

Authorium Named to GovTech 100 for Second Consecutive Year

Authorium recognized as a top company serving government agencies on nationwide list SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 21, 2025 / Authorium, the cloud-based technology platform that automates and improves complex government processes, announces today that it has been included on the GovTech 100 list for the second consecutive year. Honorees are selected

PATRIOT ANNOUNCES CLOSING OF C$69 MILLION STRATEGIC INVESTMENT, OFFTAKE AND STRATEGIC PARTNERSHIP WITH VOLKSWAGEN AND POWERCO

January 22, 2025 – Sydney, Australia Patriot Battery Metals Inc. (the “Company”or “Patriot”) (TSX: PMET) (ASX: PMT) (OTCQX: PMETF) (FSE: R9GA) is pleased to announce that it has closed its previously announced private placement for proceeds of C$69 million1 or US$48 million (the “Strategic Investment”) to Volkswagen Group (“Volkswagen” or “VW”). Following the closing of

Marriott International Announces Release Date For Fourth Quarter 2024 Earnings

Marriott International, Inc. (Nasdaq: MAR) will report fourth quarter 2024 earnings results on Tuesday, February 11, 2025, at approximately 7:00 a.m. Eastern Time (ET). The company will hold a conference call for the investment community on Tuesday, February 11, 2025, at 8:30 a.m. (ET). Marriott International's President and Chief Executive Officer, Anthony Capuano, and Chief

USNDA Forms Inter-Service U.S. Military Competitive Drone Teams, U.S. Marines First to Fight in International Military Drone Crucible Championship on Independence Day Week

Today, theUSNDAannounced its sponsorship of the first interservice, international U.S. Military Drone Crucible Championship (MDCC), to measure, incentivize and rapidly integrate small drone skills and capabilities across the armed services. The MDCC will develop camaraderie across services and allied partners, and exchange lessons learned from the rapidly growing field of emerging drone technology to hone

MSC INDUSTRIAL SUPPLY’S SARA DULSKI APPOINTED TO SERVE ON INDUSTRY SUPPLY ASSOCIATION BOARD OF DIRECTORS

MSC INDUSTRIAL SUPPLY CO. (NYSE: MSM),a premier distributor of Metalworking and Maintenance, Repair and Operations supplies to industrial customers throughoutNorth America, today announced that Sara Dulski, General Manager, Metalworking, has been appointed to serve on theIndustry Supply Association (ISA) Board of Directors. https://mma.prnewswire.com/media/2602934/MSC_Industrial_Supply_Co___Sara_Dulski___Headshot.jpg At MSC, Sara leads a portfolio that includes metalworking production tools and

RAMM Pharma Corp. Provides Update on Canapar

(CNSX:RAMM.CN),(CNSX:RAMM),(OTC US:RAMMF),(Other OTC:RAMMF), Not for Dissemination in the US or through US Newswire Services TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM), is exploring strategic options for the potential sale of its subsidiary, Canapar Corp., and/or its industrial facility located in Ragusa,

Adagene to Announce Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA(R) (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium

(NasdaqGM:ADAG), SAN DIEGO and SUZHOU, China, Jan. 21, 2025 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced it will share updated clinical data from ADG126 in microsatellite stable colorectal cancer (MSS CRC) at the ASCO Gastrointestinal (GI) Cancers Symposium in San Francisco,

ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI

(NASDAQ:ALXO), Webcast on January 23 at 1:00 p.m. PT/4:00 p.m. ET will review updated data from trial evaluating CD47-blocker evorpacept in HER2-positive gastric cancer SOUTH SAN FRANCISCO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune

Scroll to Top